These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
209 related items for PubMed ID: 26355291
21. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia. Bassler D. Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104 [Abstract] [Full Text] [Related]
22. Hospital variation and risk factors for bronchopulmonary dysplasia in a population-based cohort. Lapcharoensap W, Gage SC, Kan P, Profit J, Shaw GM, Gould JB, Stevenson DK, O'Brodovich H, Lee HC. JAMA Pediatr; 2015 Feb; 169(2):e143676. PubMed ID: 25642906 [Abstract] [Full Text] [Related]
23. Lung Ultrasound in Bronchopulmonary Dysplasia: Patterns and Predictors in Very Preterm Infants. Aldecoa-Bilbao V, Velilla M, Teresa-Palacio M, Esponera CB, Barbero AH, Sin-Soler M, Sanz MI, Salvia Roigés MD. Neonatology; 2021 Feb; 118(5):537-545. PubMed ID: 34515177 [Abstract] [Full Text] [Related]
24. Volumetric Capnography at 36 Weeks Postmenstrual Age and Bronchopulmonary Dysplasia in Very Preterm Infants. Neumann RP, Gerull R, Zannin E, Fouzas S, Schulzke SM. J Pediatr; 2022 Feb; 241():97-102.e2. PubMed ID: 34687691 [Abstract] [Full Text] [Related]
25. Oxygen saturation/FIO2 ratio at 36 weeks' PMA in 1005 preterm infants: Effect of gestational age and early respiratory disease patterns. Nobile S, Marchionni P, Gidiucci C, Correani A, Palazzi ML, Spagnoli C, Rondina C, Marche Neonatal Network, Carnielli VP. Pediatr Pulmonol; 2019 May; 54(5):637-643. PubMed ID: 30688034 [Abstract] [Full Text] [Related]
30. Exploring clinical, echocardiographic and molecular biomarkers to predict bronchopulmonary dysplasia. Alvarez-Fuente M, Moreno L, Lopez-Ortego P, Arruza L, Avila-Alvarez A, Muro M, Gutierrez E, Zozaya C, Sanchez-Helguera G, Elorza D, Martinez-Ramas A, Villar G, Labrandero C, Martinez L, Casado T, Cuadrado I, Del Cerro MJ. PLoS One; 2019 Nov; 14(3):e0213210. PubMed ID: 30840669 [Abstract] [Full Text] [Related]
31. NTproBNP as a surrogate biomarker for early screening of pulmonary hypertension in preterm infants with bronchopulmonary dysplasia. Dasgupta S, Aly AM, Malloy MH, Okorodudu AO, Jain SK. J Perinatol; 2018 Sep; 38(9):1252-1257. PubMed ID: 29977013 [Abstract] [Full Text] [Related]
33. Ceramides in tracheal aspirates of preterm infants: Marker for bronchopulmonary dysplasia. van Mastrigt E, Zweekhorst S, Bol B, Tibboel J, van Rosmalen J, Samsom JN, Kroon AA, de Jongste JC, Reiss IKM, Post M, Pijnenburg MW. PLoS One; 2018 Sep; 13(1):e0185969. PubMed ID: 29346372 [Abstract] [Full Text] [Related]
38. Predictive value of serum MED1 and PGC-1α for bronchopulmonary dysplasia in preterm infants. Li M, Sun W, Fu C, Xu S, Wang C, Chen H, Zhu X. BMC Pulm Med; 2024 Jul 28; 24(1):363. PubMed ID: 39069619 [Abstract] [Full Text] [Related]
39. N-terminal propeptide of type III collagen in tracheal fluid and serum in preterm infants at risk for bronchopulmonary dysplasia. Heikinheimo M, Halila R, Marttinen E, Raivio K. Pediatr Res; 1992 Apr 28; 31(4 Pt 1):340-3. PubMed ID: 1570200 [Abstract] [Full Text] [Related]